The first batch of RWA.ART mining machines will officially go on sale at 20:00 on September 11.
BlockBeats News, September 11, according to official sources, RWA.ART mining machines will officially go on sale at 20:00 (UTC+8) on September 11. The first batch consists of 500 machines, each priced at 200,000 BUCOIN.
According to the official introduction, the RWA.ART mining machine is an important infrastructure of the RWA.ART platform. By purchasing mining machines, users can continuously generate the platform token $ART and enjoy subsequent airdrops and ecosystem benefits. At the same time, the mining machines feature a synthesis and upgrade mechanism, allowing users to obtain higher returns through synthesis. If synthesis fails, users will receive double minting rights as compensation.
RWA.ART stated that mining machines are not only tools for obtaining platform token ART rewards, but also an important entry point for users to participate in ecosystem development, enabling community members to share in the platform's long-term growth value.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
BNP Paribas gives Microsoft (MSFT.US) a "Buy" rating: Azure price increases will be gradually implemented after contract renewals, and a deal with SpaceX may be announced soon.
BNP Paribas has rated Microsoft as "Buy" with a target price of $549.
Iranian President will head to New York for UN meeting
"Big Short" Burry opens a position in QXO (QXO.US), betting on building products integration and undervaluation; stock price rises over 7%
Investor Michael Burry disclosed that he has purchased common and preferred shares of QXO (QXO.US), a building products company, citing its integration strategy and the currently depressed stock price. The stock surged 7.2% on Monday.
700,000 new elderly patients join, Eli Lilly (LLY.US) dominates 70%: The first Medicare weight loss drug coverage report released
Dave Ricks, CEO of Eli Lilly (LLY.US), said in an interview on Monday that since Medicare began coverage for obesity drugs in July, 700,000 new elderly patients have started using GLP-1 medications.
